» Authors » M K Drezner

M K Drezner

Explore the profile of M K Drezner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 3212
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Binkley N, Lappe J, Singh R, Khosla S, Krueger D, Drezner M, et al.
Osteoporos Int . 2015 Jan; 26(5):1655-60. PMID: 25572049
Unlabelled: Substantial variability exists in the serum 25(OH)D increase observed in response to vitamin D supplementation. Measurement of circulating cholecalciferol and 24,25(OH)₂D, as indicators of vitamin D absorption and degradation,...
2.
Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D, et al.
J Clin Endocrinol Metab . 2011 Feb; 96(4):981-8. PMID: 21289249
Context: Whether ergocalciferol (D(2)) and cholecalciferol (D(3)) are equally effective to increase and maintain serum 25-hydroxyvitamin D [25(OH)D] concentration is controversial. Objective: The aim of the study was to evaluate...
3.
Binkley N, Krueger D, Gemar D, Drezner M
J Clin Endocrinol Metab . 2008 Mar; 93(5):1804-8. PMID: 18319318
Context: Measurement of circulating 25-hydroxy-vitamin D [25(OH)D]) is the accepted clinical indicator of vitamin D status. However, between-laboratory differences in measurement of this analyte exist, which may confound clinical care....
4.
Binkley N, Novotny R, Krueger D, Kawahara T, Daida Y, Lensmeyer G, et al.
J Clin Endocrinol Metab . 2007 Apr; 92(6):2130-5. PMID: 17426097
Context: Lack of sun exposure is widely accepted as the primary cause of epidemic low vitamin D status worldwide. However, some individuals with seemingly adequate UV exposure have been reported...
5.
Blank R, Malone D, Christian R, Vallarta-Ast N, Krueger D, Drezner M, et al.
Osteoporos Int . 2006 Jan; 17(5):768-74. PMID: 16435075
Introduction: Changes in bone mineral density are used to monitor osteoporosis therapy. To determine whether a change in bone mass is clinically significant, the precision of bone mineral density measurements...
6.
Reginster J, Adami S, Lakatos P, Greenwald M, Stepan J, Silverman S, et al.
Ann Rheum Dis . 2005 Dec; 65(5):654-61. PMID: 16339289
Background: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. Objective: To...
7.
Binkley N, Krueger D, Gangnon R, Genant H, Drezner M
Osteoporos Int . 2005 Apr; 16(12):1513-8. PMID: 15834512
Although many vertebral fractures are clinically silent, they are associated with increased risk for subsequent osteoporotic fractures. A substantial number of these fractures are demonstrable using instant vertebral assessment with...
8.
Binkley N, Krueger D, Cowgill C, Plum L, Lake E, Hansen K, et al.
J Clin Endocrinol Metab . 2004 Jul; 89(7):3152-7. PMID: 15240586
Endemic hypovitaminosis D contributes to osteoporosis development. However, variation in 25-hydroxyvitamin D (25OHD) measurement is reported and confounds the diagnosis of vitamin D insufficiency/deficiency. This report emphasizes the marked variability...
9.
Rowe P, Kumagai Y, Gutierrez G, Garrett I, Blacher R, Rosen D, et al.
Bone . 2004 Feb; 34(2):303-19. PMID: 14962809
Matrix extracellular phosphoglycoprotein (MEPE) is expressed exclusively in osteoblasts, osteocytes and odontoblasts with markedly elevated expression found in X-linked hypophosphatemic rickets (Hyp) osteoblasts and in oncogenic hypophosphatemic osteomalacia (OHO) tumors....
10.
Hans D, Genton L, Drezner M, Schott A, Pacifici R, Avioli L, et al.
Calcif Tissue Int . 2002 Aug; 71(2):112-20. PMID: 12200644
Many studies have been done involving exercise, impact loading, and the effect on BMD. In some of these studies, particularly those involving outpatient activity, compliance and the specific parameters of...